| 000 | 01623 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515171404.0 | ||
| 264 | 0 | _c20090623 | |
| 008 | 200906s 0 0 eng d | ||
| 022 | _a1091-6490 | ||
| 024 | 7 |
_a10.1073/pnas.0901505106 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTherapontos, Christina | |
| 245 | 0 | 0 |
_aThalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation. _h[electronic resource] |
| 260 |
_bProceedings of the National Academy of Sciences of the United States of America _cMay 2009 |
||
| 300 |
_a8573-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aChick Embryo |
| 650 | 0 | 4 |
_aCytoskeleton _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
| 650 | 0 | 4 |
_aLimb Deformities, Congenital _xchemically induced |
| 650 | 0 | 4 | _aNeovascularization, Physiologic |
| 650 | 0 | 4 |
_aPseudopodia _xdrug effects |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aThalidomide _xanalogs & derivatives |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aErskine, Lynda | |
| 700 | 1 | _aGardner, Erin R | |
| 700 | 1 | _aFigg, William D | |
| 700 | 1 | _aVargesson, Neil | |
| 773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 106 _gno. 21 _gp. 8573-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.0901505106 _zAvailable from publisher's website |
| 999 |
_c18861653 _d18861653 |
||